Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2001 Dec;10(6):285–288. doi: 10.1080/09629350120102000

Molecular mechanisms of atopy.

P J Barnes 1
PMCID: PMC1781729  PMID: 11817661

Full Text

The Full Text of this article is available as a PDF (107.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akdis C. A., Blesken T., Akdis M., Wüthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998 Jul 1;102(1):98–106. doi: 10.1172/JCI2250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. J. Anti-IgE antibody therapy for asthma. N Engl J Med. 1999 Dec 23;341(26):2006–2008. doi: 10.1056/NEJM199912233412610. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):5–16. doi: 10.1067/mai.2000.107930. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J. Therapeutic strategies for allergic diseases. Nature. 1999 Nov 25;402(6760 Suppl):B31–B38. doi: 10.1038/35037026. [DOI] [PubMed] [Google Scholar]
  5. Benjaponpitak S., Oro A., Maguire P., Marinkovich V., DeKruyff R. H., Umetsu D. T. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):468–475. doi: 10.1016/s0091-6749(99)70473-2. [DOI] [PubMed] [Google Scholar]
  6. Boguniewicz M., Martin R. J., Martin D., Gibson U., Celniker A., Williams M., Leung D. Y. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):133–135. doi: 10.1016/s0091-6749(95)70162-1. [DOI] [PubMed] [Google Scholar]
  7. Borish L. C., Nelson H. S., Lanz M. J., Claussen L., Whitmore J. B., Agosti J. M., Garrison L. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med. 1999 Dec;160(6):1816–1823. doi: 10.1164/ajrccm.160.6.9808146. [DOI] [PubMed] [Google Scholar]
  8. Borish L., Aarons A., Rumbyrt J., Cvietusa P., Negri J., Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol. 1996 Jun;97(6):1288–1296. doi: 10.1016/s0091-6749(96)70197-5. [DOI] [PubMed] [Google Scholar]
  9. Bryan S. A., O'Connor B. J., Matti S., Leckie M. J., Kanabar V., Khan J., Warrington S. J., Renzetti L., Rames A., Bock J. A. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000 Dec 23;356(9248):2149–2153. doi: 10.1016/S0140-6736(00)03497-8. [DOI] [PubMed] [Google Scholar]
  10. Chomarat P., Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17(1-4):1–52. doi: 10.3109/08830189809084486. [DOI] [PubMed] [Google Scholar]
  11. Chung K. F., Barnes P. J. Cytokines in asthma. Thorax. 1999 Sep;54(9):825–857. doi: 10.1136/thx.54.9.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Corry D. B., Kheradmand F. Induction and regulation of the IgE response. Nature. 1999 Nov 25;402(6760 Suppl):B18–B23. doi: 10.1038/35037014. [DOI] [PubMed] [Google Scholar]
  13. Devalia J. L., Davies R. J. Airway epithelial cells and mediators of inflammation. Respir Med. 1993 Aug;87(6):405–408. doi: 10.1016/0954-6111(93)90064-7. [DOI] [PubMed] [Google Scholar]
  14. Durham S. R., Ying S., Varney V. A., Jacobson M. R., Sudderick R. M., Mackay I. S., Kay A. B., Hamid Q. A. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol. 1996 Jun;97(6):1356–1365. doi: 10.1016/s0091-6749(96)70205-1. [DOI] [PubMed] [Google Scholar]
  15. Fahy J. V., Fleming H. E., Wong H. H., Liu J. T., Su J. Q., Reimann J., Fick R. B., Jr, Boushey H. A. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med. 1997 Jun;155(6):1828–1834. doi: 10.1164/ajrccm.155.6.9196082. [DOI] [PubMed] [Google Scholar]
  16. Gately M. K., Renzetti L. M., Magram J., Stern A. S., Adorini L., Gubler U., Presky D. H. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 1998;16:495–521. doi: 10.1146/annurev.immunol.16.1.495. [DOI] [PubMed] [Google Scholar]
  17. Gavett S. H., O'Hearn D. J., Li X., Huang S. K., Finkelman F. D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med. 1995 Nov 1;182(5):1527–1536. doi: 10.1084/jem.182.5.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grünig G., Warnock M., Wakil A. E., Venkayya R., Brombacher F., Rennick D. M., Sheppard D., Mohrs M., Donaldson D. D., Locksley R. M. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998 Dec 18;282(5397):2261–2263. doi: 10.1126/science.282.5397.2261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Haczku A., Takeda K., Redai I., Hamelmann E., Cieslewicz G., Joetham A., Loader J., Lee J. J., Irvin C., Gelfand E. W. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1638–1643. doi: 10.1164/ajrccm.159.5.9711040. [DOI] [PubMed] [Google Scholar]
  20. Holt P. G., Sly P. D. Prevention of adult asthma by early intervention during childhood: potential value of new generation immunomodulatory drugs. Thorax. 2000 Aug;55(8):700–703. doi: 10.1136/thorax.55.8.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Holt P. G., Stumbles P. A. Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J Allergy Clin Immunol. 2000 Mar;105(3):421–429. doi: 10.1067/mai.2000.105010. [DOI] [PubMed] [Google Scholar]
  22. Humbert M., Durham S. R., Kimmitt P., Powell N., Assoufi B., Pfister R., Menz G., Kay A. B., Corrigan C. J. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol. 1997 May;99(5):657–665. doi: 10.1016/s0091-6749(97)70028-9. [DOI] [PubMed] [Google Scholar]
  23. Jardieu P. M., Fick R. B., Jr IgE inhibition as a therapy for allergic disease. Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):112–115. doi: 10.1159/000024043. [DOI] [PubMed] [Google Scholar]
  24. John M., Lim S., Seybold J., Jose P., Robichaud A., O'Connor B., Barnes P. J., Chung K. F. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med. 1998 Jan;157(1):256–262. doi: 10.1164/ajrccm.157.1.9703079. [DOI] [PubMed] [Google Scholar]
  25. Kim T. S., DeKruyff R. H., Rupper R., Maecker H. T., Levy S., Umetsu D. T. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol. 1997 May 1;158(9):4137–4144. [PubMed] [Google Scholar]
  26. Kohno K., Kurimoto M. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol. 1998 Jan;86(1):11–15. doi: 10.1006/clin.1997.4475. [DOI] [PubMed] [Google Scholar]
  27. Lack G., Bradley K. L., Hamelmann E., Renz H., Loader J., Leung D. Y., Larsen G., Gelfand E. W. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol. 1996 Aug 15;157(4):1432–1439. [PubMed] [Google Scholar]
  28. Leckie M. J., ten Brinke A., Khan J., Diamant Z., O'Connor B. J., Walls C. M., Mathur A. K., Cowley H. C., Chung K. F., Djukanovic R. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000 Dec 23;356(9248):2144–2148. doi: 10.1016/s0140-6736(00)03496-6. [DOI] [PubMed] [Google Scholar]
  29. Levitt R. C., McLane M. P., MacDonald D., Ferrante V., Weiss C., Zhou T., Holroyd K. J., Nicolaides N. C. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol. 1999 May;103(5 Pt 2):S485–S491. doi: 10.1016/s0091-6749(99)70165-x. [DOI] [PubMed] [Google Scholar]
  30. Li L., Xia Y., Nguyen A., Lai Y. H., Feng L., Mosmann T. R., Lo D. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol. 1999 Mar 1;162(5):2477–2487. [PubMed] [Google Scholar]
  31. Lim S., Crawley E., Woo P., Barnes P. J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 1998 Jul 11;352(9122):113–113. doi: 10.1016/S0140-6736(98)85018-6. [DOI] [PubMed] [Google Scholar]
  32. Milgrom H., Fick R. B., Jr, Su J. Q., Reimann J. D., Bush R. K., Watrous M. L., Metzger W. J. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med. 1999 Dec 23;341(26):1966–1973. doi: 10.1056/NEJM199912233412603. [DOI] [PubMed] [Google Scholar]
  33. Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996 Mar;17(3):138–146. doi: 10.1016/0167-5699(96)80606-2. [DOI] [PubMed] [Google Scholar]
  34. Ochi H., De Jesus N. H., Hsieh F. H., Austen K. F., Boyce J. A. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10509–10513. doi: 10.1073/pnas.180318697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pretolani M., Goldman M. IL-10: a potential therapy for allergic inflammation? Immunol Today. 1997 Jun;18(6):277–280. doi: 10.1016/s0167-5699(97)80023-0. [DOI] [PubMed] [Google Scholar]
  36. Saunders M. A., Mitchell J. A., Seldon P. M., Yacoub M. H., Barnes P. J., Giembycz M. A., Belvisi M. G. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol. 1997 Feb;120(4):545–546. doi: 10.1038/sj.bjp.0700998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Spiteri M. A., Knight R. A., Jeremy J. Y., Barnes P. J., Chung K. F. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J. 1994 Aug;7(8):1431–1438. doi: 10.1183/09031936.94.07081431. [DOI] [PubMed] [Google Scholar]
  38. Strachan D. P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax. 2000 Aug;55 (Suppl 1):S2–10. doi: 10.1136/thorax.55.suppl_1.s2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Stumbles P. A., Thomas J. A., Pimm C. L., Lee P. T., Venaille T. J., Proksch S., Holt P. G. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med. 1998 Dec 7;188(11):2019–2031. doi: 10.1084/jem.188.11.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tsicopoulos A., Joseph M. The role of CD23 in allergic disease. Clin Exp Allergy. 2000 May;30(5):602–605. doi: 10.1046/j.1365-2222.2000.00871.x. [DOI] [PubMed] [Google Scholar]
  41. Van Neerven R. J., Van de Pol M. M., Van der Zee J. S., Stiekema F. E., De Boer M., Kapsenberg M. L. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy. 1998 Jul;28(7):808–816. doi: 10.1046/j.1365-2222.1998.00306.x. [DOI] [PubMed] [Google Scholar]
  42. Van Oosterhout A. J., Hofstra C. L., Shields R., Chan B., Van Ark I., Jardieu P. M., Nijkamp F. P. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Respir Cell Mol Biol. 1997 Sep;17(3):386–392. doi: 10.1165/ajrcmb.17.3.2679. [DOI] [PubMed] [Google Scholar]
  43. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T. Y., Karp C. L., Donaldson D. D. Interleukin-13: central mediator of allergic asthma. Science. 1998 Dec 18;282(5397):2258–2261. doi: 10.1126/science.282.5397.2258. [DOI] [PubMed] [Google Scholar]
  44. Zuany-Amorim C., Hailé S., Leduc D., Dumarey C., Huerre M., Vargaftig B. B., Pretolani M. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest. 1995 Jun;95(6):2644–2651. doi: 10.1172/JCI117966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. de Vries J. E., Carballido J. M., Aversa G. Receptors and cytokines involved in allergic TH2 cell responses. J Allergy Clin Immunol. 1999 May;103(5 Pt 2):S492–S496. doi: 10.1016/s0091-6749(99)70166-1. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES